Page last updated: 2024-10-15

plantainoside d

Description

plantainoside D: antioxidant from the leaves of Picrorhiza scrophulariiflora (Scrophulariaceae); structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Picrorhiza scrophulariifloraspecies[no description available]PlantaginaceaeA plant family of order Lamiales. The Plantago genus is best known. Lesser known members include Hippuris, Littorella and Callitriche.[MeSH]

Cross-References

ID SourceID
PubMed CID154809630
SCHEMBL ID23512286
MeSH IDM0506449

Synonyms (6)

Synonym
plantainoside d
SCHEMBL23512286
147331-98-4
isoplantamajoside
3,4-dihydroxyphenethyl 3-o-beta-d-glucopyranosyl-6-o-(3,4-dihydroxycinnamoyl)-beta-d-glucopyranoside
AKOS040758813

Research Excerpts

Overview

Plantainoside D (PD) is a potential anti-hypertensive active ingredient. PD was newly isolated from the dried plants of Chirita longgangensis var.

ExcerptReference
"Plantainoside D (PD) is a potential anti-hypertensive active ingredient newly isolated from the dried plants of Chirita longgangensis var. "( LC-ESI-MS/MS analysis and pharmacokinetics of plantainoside D isolated from Chirita longgangensis var. hongyao, a potential anti-hypertensive active component in rats.
Fu, S; Gong, M; Li, J; Qiu, F; Wang, M; Zhang, X, 2014
)

Pharmacokinetics

ExcerptReference
" The present method has been applied for pharmacokinetic study of PD after oral and intravenous administration in rats."( LC-ESI-MS/MS analysis and pharmacokinetics of plantainoside D isolated from Chirita longgangensis var. hongyao, a potential anti-hypertensive active component in rats.
Fu, S; Gong, M; Li, J; Qiu, F; Wang, M; Zhang, X, 2014
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's2 (33.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]